Cardiovascular Disease Epidemiology

Cardiovascular disease epidemiology studies the occurrence, distribution, and determinants of diseases of the heart and blood vessels - chiefly ischaemic heart disease and stroke - across populations. Cardiovascular disease (CVD) is the leading cause of death worldwide, and its epidemiology has shaped the modern concept of a chronic-disease 'risk factor'.

Definition

The branch of epidemiology concerned with the frequency, distribution, and causes of diseases of the circulatory system, especially coronary heart disease and cerebrovascular disease, and with the risk factors that predict them.

Scope

The entry covers how CVD is defined and counted (mortality, incidence, prevalence, DALYs), its principal modifiable and non-modifiable risk factors, geographic and temporal trends, and the landmark cohort studies that established the risk-factor paradigm. It is a reference topic on disease epidemiology, not clinical guidance.

Core questions

• How much of global mortality and disability does cardiovascular disease cause, and how is it distributed?
• Which risk factors predict cardiovascular events, and how were they established?
• How have CVD rates changed over time and across regions?

Key concepts

• Risk factor concept
• Ischaemic (coronary) heart disease
• Stroke (cerebrovascular disease)
• Atherosclerosis
• Blood pressure and lipids as continuous risks
• Population versus high-risk prevention strategy
• Age-standardised mortality

Mechanisms

Most cardiovascular disease burden arises from atherosclerosis - the progressive accumulation of lipid and inflammatory plaque in arterial walls - and from hypertension-driven vascular and cardiac damage. Epidemiologically, several risk factors act as graded, largely continuous exposures: blood pressure, LDL cholesterol, smoking, diabetes, and adiposity each raise event risk in a dose-dependent way, and they combine roughly multiplicatively, which is why absolute risk is estimated from the full risk-factor profile rather than any single marker (Roth et al., 2020; Martin et al., 2024).

Clinical relevance

Cardiovascular epidemiology underpins how populations are screened, how risk is communicated, and how prevention is prioritised; the risk-factor concept it generated is now central to preventive medicine. This entry describes how that evidence is produced and is not a substitute for individual clinical assessment or treatment decisions.

Epidemiology

Cardiovascular disease accounts for roughly a third of all global deaths and is the single largest cause of mortality, with ischaemic heart disease and stroke dominating the burden (Roth et al., 2020; Vos et al., 2020). Age-standardised CVD mortality has fallen in many high-income countries since the late twentieth century, but absolute case numbers continue to rise with population ageing and growth, and burden is shifting toward low- and middle-income countries (Roth et al., 2020; Martin et al., 2024).

Evidence & guidelines

The descriptive evidence base rests on the Global Burden of Disease estimates and on national surveillance such as the American Heart Association statistical updates (Roth et al., 2020; Martin et al., 2024). The analytic foundation - the identification of modifiable risk factors - came from prospective cohort studies, most famously the Framingham Heart Study (Dawber et al., 1951).

History

Cardiovascular epidemiology emerged in the mid-twentieth century as heart disease mortality rose in industrialised countries. The Framingham Heart Study, begun in 1948 and described by Dawber and colleagues in 1951, followed a community cohort prospectively and introduced the term 'risk factor', establishing smoking, blood pressure, and cholesterol as predictors of coronary disease. Subsequent cross-population work (such as the Seven Countries Study) and the Global Burden of Disease programme extended this to a worldwide descriptive picture.

Debates

Population-wide versus high-risk prevention

Geoffrey Rose argued that shifting an entire population's risk-factor distribution downward can prevent more events than targeting only high-risk individuals; the relative emphasis of these strategies remains a live question in cardiovascular prevention policy.

Key figures

• Thomas Royle Dawber
• Geoffrey Rose
• Jeremiah Stamler

Seminal works

• dawber-1951
• roth-2020

Frequently asked questions

Is cardiovascular disease still the leading cause of death?

Yes. Cardiovascular disease, mainly ischaemic heart disease and stroke, remains the single largest cause of death worldwide, even though age-standardised death rates have fallen in many high-income countries.

Where does the 'risk factor' idea come from?

The term and its quantitative use originated in the Framingham Heart Study in the 1950s, which followed a community cohort and showed that smoking, blood pressure, and cholesterol predicted later coronary events.